Showing 19,841 - 19,860 results of 100,757 for search '(( 5 step decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.08s Refine Results
  1. 19841
  2. 19842
  3. 19843
  4. 19844
  5. 19845
  6. 19846

    Tumor Cells Switch to Mitochondrial Oxidative Phosphorylation under Radiation via mTOR-Mediated Hexokinase II Inhibition - A Warburg-Reversing Effect by Chung-Ling Lu (711442)

    Published 2015
    “…Three tumor cell lines (breast cancer MCF-7, colon cancer HCT116 and glioblastoma U87) showed a quick relocation of mTOR to mitochondria after irradiation with a single dose 5 Gy, which was companied with decreased lactate production, increased mitochondrial ATP generation and oxygen consumption. …”
  7. 19847
  8. 19848

    Conformational characterization of a novel anti-HER2 candidate antibody by Leina Moro Pérez (6686177)

    Published 2019
    “…In this work, the conformational features of a novel monoclonal antibody (called 5G4) were evaluated by means of circular dichroism spectroscopy and fluorescence. …”
  9. 19849
  10. 19850

    <em>In Vitro</em> and <em>Ex Vivo</em> Analysis of <em>CHRNA3</em> and <em>CHRNA5</em> Haplotype Expression by Glenn A. Doyle (209929)

    Published 2011
    “…For <em>in vitro</em> analyses, promoter haplotypes were sub-cloned into a luciferase reporter vector. When assessed in BE(2)-C cells, luciferase expression was equivalent among <em>CHRNA3</em> haplotypes, but the combination of deletion at rs3841324 and variation at rs503464 decreased <em>CHRNA5</em> promoter-derived luciferase activity, possibly due to loss of an SP-1 and other site(s). …”
  11. 19851
  12. 19852
  13. 19853
  14. 19854

    Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-s... by Sanne Verdoorn (6680822)

    Published 2019
    “…Over 6 months, in the intervention group, HR-QoL measured with EQ-VAS increased by 3.4 points (95% confidence interval [CI] 0.94 to 5.8; <i>p</i> = 0.006), and the number of health problems with impact on daily life decreased by 12% (difference at 6 months −0.34; 95% CI −0.62 to −0.044; <i>p</i> = 0.024) as compared with the control group. …”
  15. 19855
  16. 19856
  17. 19857
  18. 19858

    Changes in ELF5, FOXA1 and ER binding to the genome are reflected in gene expression. by Catherine L. Piggin (8212272)

    Published 2020
    “…Panel <b>B</b>, as for panel A but showing genes for which FOXA1 or ER binding was increased or decreased by induction of ELF5. …”
  19. 19859

    ELF5 transcriptional effects measured by RNA-seq. by Catherine L. Piggin (8212272)

    Published 2020
    “…<p>Panel <b>A</b>, GO ontologies enriched in the RNA-seq data set by induction of ELF5, font size relative to enrichment score. …”
  20. 19860

    The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor by Elizabeth A. Coe (8195508)

    Published 2019
    “…<i>DIRC3</i> is a nuclear lncRNA that activates expression of its neighbouring <i>IGFBP5</i> tumour suppressor through modulating chromatin structure and suppressing SOX10 binding to putative regulatory elements within the <i>DIRC3</i> locus. …”